Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Doxium for Abnormal Uterine Bleeding
NCT06707051Phase 3Completed
- Sponsor
- DHQ Teaching Hospital Sahiwal
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of calcium dobesilate in abnormal uterine bleeding (AUB) (2 arms), sponsored by DHQ Teaching Hospital Sahiwal. Primary endpoint: Reduction in menstrual blood loss at 3 months. Started Jan 2022; status: completed.
02
Drugs
calcium dobesilate
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT06707051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06707051.